Neurol. praxi. 2011;12(5):368-370

Masarykova univerzita, Brno

doc.MUDr.Robert Kuba, Ph.D.1,2
1 Centrum pro epilepsie Brno, 1. neurologická klinika LF MU ve FN u sv. Anny, Brno
2 Výzkumná skupina pro behaviorální a sociální neurovědy, Středoevropský technologický institut (CEITEC),

Published: November 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kuba R. Masarykova univerzita, Brno. Neurol. praxi. 2011;12(5):368-370.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Canevini MP, De Sarro G, Galimberti CA, Gatti G, Licchetta L, Malerba A, Muscas G, La Neve A, Striano P, Perucca E, SOPHIE Study. Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy. Epilepsia 2010; 51: 797-804. Go to original source... Go to PubMed...
    2. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clinical Therapeutics 2001; 23: 1296-1310. Go to original source... Go to PubMed...
    3. Harden CL, Meador KJ, Pennell PB, Hauser WA, Gronseth GS, French JA, Wiebe S, Thurman D, Koppel BS, Kaplan PW, Robinson JN, Hopp J, Ting TY, Gidal B, Hovinga CA, Wilner AN, Vazquez B, Holmes L, Krumholz A, Finnel R, Vazquez B, Holmes L, Krumholz A, Finnell R, Hirtz D, Le Guen C, American Acadamy of neurology, American Epilepsy Society. Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes: Report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 2009; 50: 1237-1246. Go to original source... Go to PubMed...
    4. Holland KD, Glauser TA. Response to carbamazepine in children with newly diagnosed partial onset epilepsy. Neurology 2007; 69: 596-599. Go to original source... Go to PubMed...
    5. Kwan P, Brodie MJ. Early identification of refraktory epilepsy. N Eng J Med 2000; 342: 314-319. Go to original source... Go to PubMed...
    6. Patsalos PN, Perucca E. Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs. Lancet Neurol. 2003; 2: 347-356. Go to original source... Go to PubMed...
    7. ##
    8. Brodie MJ, Sills. Combining antiepileptic drugs - Rational polytherapy? Seizure, 2011: 369-375. Go to original source... Go to PubMed...
    9. Deckers CLP, Czuczwar SJ, Hekster YA, Kewser A, Kubová H, Meinardi H, Potsalos PN, Renier WO, Van Rijn CM. Selection of antiepileptic drug polytherapy based on mechanism of action: the evidence reviewed. Epilepsia 2000; 41: 1364-1374. Go to original source... Go to PubMed...
    10. Dolanský J. Současná epileptologie, Triton, Praha 2000.
    11. Hovorka J, Nežádal T. Kombinovaná léčba antiepileptiky u epilepsie: taktika, volba léků, interakce, Neurol. prax, 2007; 2: 76-82.
    12. St. Louis EK. Truly "Rational" Polytherapy: Maximizing Efficacy and Minimizing Drug Interactions, Drug Load, and Adverse Effects Curr Neuropharmacol. 2009; 7(2): 96-105. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.